Targetable Mutations and First-Line Treatment Options for Metastatic Non-Small Cell Lung Cancer

This chapter discusses various targetable mutations and their corresponding treatment options for metastatic non-small cell lung cancer, including specific drugs for different mutations and treatment options for HER2 mutations or amplifications. It also mentions the standard first-line treatment involving immunotherapy and chemotherapy.